Related by context. Frequent words. (Click for all words.) 69 metastatic renal cell carcinoma 68 BAY #-# 68 active comparator 68 axitinib 68 plus prednisone 67 dacarbazine 67 resistant ovarian cancer 66 aflibercept 66 neoadjuvant 66 hormone refractory prostate cancer 66 randomized Phase III 65 sunitinib 65 castration resistant prostate cancer 65 FOLFIRI 65 refractory multiple myeloma 65 nab paclitaxel 65 IMC A# 65 relapsed multiple myeloma 64 temsirolimus 64 RG# [001] 64 SCH # 64 multicenter clinical 64 vinorelbine 64 placebo controlled randomized 64 HRPC 64 vandetanib 64 TELCYTA 64 seliciclib 64 prospective randomized controlled 64 lupus nephritis 64 rNAPc2 63 non squamous 63 Phase 2a trial 63 multicenter randomized 63 CA4P 63 Phase 2b study 63 pazopanib 63 thymalfasin 63 phase IIb 63 decitabine 63 diabetic neuropathic pain 62 FOLFOX 62 cutaneous T cell 62 dose cohorts 62 HGS ETR1 62 neoadjuvant chemotherapy 62 tocilizumab 62 INCB# [002] 62 peg IFN 62 Phase 2b clinical 62 Phase 2a clinical 62 peginterferon alfa 2b 62 unresectable 62 Torisel 62 Bevacizumab 62 Bortezomib 62 dabigatran etexilate 62 Taxotere ® 62 gemcitabine 62 darapladib 62 Phase 2b trial 62 liver metastases 62 relapsing remitting multiple sclerosis 62 teduglutide 61 TORISEL 61 NSCLC 61 mixed dyslipidemia 61 CoFactor 61 DMARD 61 palifosfamide 61 SUTENT 61 phase IIa 61 ridaforolimus 61 tesmilifene 61 gefitinib 61 LymphoStat B 61 adefovir 61 Nexavar ® 61 Phenoptin 61 bosentan 61 Phase 1b clinical 61 bazedoxifene 61 Perifosine 61 CYC# 61 dose regimens 61 refractory Hodgkin lymphoma 61 eltrombopag 61 sapacitabine 61 fludarabine 61 nilotinib 61 free survival PFS 60 talactoferrin 60 muraglitazar 60 oxaliplatin 60 advanced NSCLC 60 TREANDA 60 blinded placebo controlled 60 valopicitabine 60 vicriviroc 60 ZYBRESTAT 60 Phase III randomized